Effect of trimetazidine treatment on the transient outward potassium current of the left ventricular myocytes of rats with streptozotocin-induced type 1 diabetes mellitus.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas
Yu-luan XiangQiang She

Abstract

Cardiovascular complications are a leading cause of mortality in patients with diabetes mellitus (DM). The present study was designed to investigate the effects of trimetazidine (TMZ), an anti-angina drug, on transient outward potassium current (Ito) remodeling in ventricular myocytes and the plasma contents of free fatty acid (FFA) and glucose in DM. Sprague-Dawley rats, 8 weeks old and weighing 200-250 g, were randomly divided into three groups of 20 animals each. The control group was injected with vehicle (1 mM citrate buffer), the DM group was injected with 65 mg/kg streptozotocin (STZ) for induction of type 1 DM, and the DM + TMZ group was injected with the same dose of STZ followed by a 4-week treatment with TMZ (60 mg·kg-1·day-1). All animals were then euthanized and their hearts excised and subjected to electrophysiological measurements or gene expression analyses. TMZ exposure significantly reversed the increased plasma FFA level in diabetic rats, but failed to change the plasma glucose level. The amplitude of Ito was significantly decreased in left ventricular myocytes from diabetic rats relative to control animals (6.25 ± 1.45 vs 20.72 ± 2.93 pA/pF at +40 mV). The DM-associated Ito reduction was attenuated by TMZ. M...Continue Reading

References

Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
Apr 1, 1997·Cardiovascular Research·W C StanleyJ G McCormack
Dec 9, 1998·The American Journal of Physiology·Z Xu, G J Rozanski
Oct 20, 1999·Journal of Molecular and Cellular Cardiology·P E MorganH E Cingolani
Apr 25, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·P RossingH H Parving
May 9, 2001·Biochemical and Biophysical Research Communications·D QinN El-Sherif
Sep 15, 2001·American Journal of Physiology. Heart and Circulatory Physiology·A NishiyamaM M Tamkun
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Apr 10, 2002·Circulation·Heinrich TaegtmeyerMartin E Young
May 8, 2004·Journal of Endocrinological Investigation·M VeglioP Cavallo-Perin
Aug 24, 2004·Current Vascular Pharmacology·O Casis, E Echevarria
Nov 13, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Xun LiGeorge J Rozanski
Sep 22, 2005·American Journal of Physiology. Endocrinology and Metabolism·Lucilla D MontiPierMarco Piatti
Sep 27, 2005·Physiological Reviews·Jeanne M Nerbonne, Robert S Kass
Jun 6, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Ding An, Brian Rodrigues
Dec 22, 2006·Cardiovascular Research·Csaba LengyelAndrás Varró
Feb 24, 2009·Canadian Journal of Physiology and Pharmacology·Mónica GallegoOscar Casis
Jul 22, 2009·Journal of Molecular and Cellular Cardiology·Noriko Niwa, Jeanne M Nerbonne
Mar 4, 2010·Acta Diabetologica·Roberto TarquiniGian Franco Gensini
Jul 17, 2010·Mediators of Inflammation·Inge A M van den OeverSuat Simsek
Jul 15, 2011·Diabetes Technology & Therapeutics·Sunil K KotaKirtikumar D Modi

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
electrophoresis

Software Mentioned

Pulse
Quantity One

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.